伴系膜区λ轻链限制的原发性IgA肾病的临床病理与预后研究
该回顾性单中心研究纳入187例伴系膜区λ轻链限制的原发性IgA肾病(IgAN-λ)患者,按1:3匹配IgA肾病患者作为对照,比较两组的临床病理与预后差异。结果显示IgAN-λ组血清纤维蛋白原水平显著高于IgAN组,随访>6年时IgAN-λ组预后显著更差,系膜区λ轻链限制是不良结局的独立危险因素。
要点
- IgAN-λ组血清纤维蛋白原水平较IgAN组显著升高(P<0.001)。
- 随访>6年时IgAN-λ组预后显著差于IgAN组(P=0.02)。
- 系膜区λ轻链限制是不良结局的独立危险因素。
核心结论
- IgAN-λ患者预后较IgAN患者更差,可能归因于系膜区λ轻链限制诱导显著的全身炎症,表现为严重的临床特征和频繁的新月体形成。
研究设计与样本
- 回顾性单中心研究,从2002年1月至2020年12月在本院经肾活检诊断为原发性IgA肾病的3872例患者中,纳入符合IgAN-λ选择标准的187例患者,并按年龄、性别、肾功能(eGFR)和随访时间以1:3匹配IgA肾病对照。
主要发现
- 与IgAN组相比,IgAN-λ组血清纤维蛋白原水平显著更高(P<0.001)。
- 聚类分析提示IgAN-λ组与IgAN组中涉及纤维蛋白原的聚类不同,且纤维蛋白原在IgAN-λ中与反映肾功能的因素相关,而在IgAN中与蛋白尿水平相关。
- 在IgAN-λ患者中,系膜区λ轻链沉积与新月体形成相关;而在IgAN患者中,系膜区λ轻链沉积与补体C3沉积相关。
- Kaplan-Meier分析显示,随访>6年时IgAN-λ组预后显著差于IgAN组(P=0.02)。
- 多因素Cox分析显示,系膜区λ轻链限制是不良结局(eGFR较基线持续下降≥30%或达到终末期肾病[ESRD]或死亡)的独立危险因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Primary IgA nephropathy (IgAN) with light chain λ restriction in the mesangial deposits (IgAN-λ) has unique immunofluorescence (IF) features. Nevertheless, its clinicopathology and prognosis are still ambiguous. METHODS: From January 2002 to December 2020, the clinical and pathologic data of 3872 patients who were diagnosed with having primary IgAN by renal biopsy in our hospital were reviewed. A total of 187 patients who met the selection criteria for IgAN-λ were enrolled to conduct a retrospective single-center study. The selection criteria were that IF features conform to light chain λ restriction in the mesangial deposits. According to age, sex, renal function (estimated glomerular filtration rate [eGFR]), and follow-up time, the control group was constructed with 1:3 matched cases of IgAN. The clinicopathologic and prognostic differences between the 2 groups were analyzed. RESULTS: Compared with that in the IgAN group, the serum fibrinogen level in the IgAN-λ group was significantly higher (P < 0.001). Furthermore, cluster analysis indicated the different clusters involved in fibrinogen between the IgAN-λ and IgAN groups and that fibrinogen is associated with factors reflecting renal function in IgAN-λ but proteinuria levels in IgAN. The light chain λ deposit in the mesangium is associated with the formation of crescents in those with IgAN-λ, but complement C3 deposition in those with IgAN. Our Kaplan-Meier analysis revealed that the prognosis of the IgAN-λ group was significantly worse than that of the IgAN group within >6 years of follow-up (P = 0.02). The multi-Cox analysis revealed that the light chain λ restriction in the mesangial deposits was an independent risk factor for poor outcomes (eGFR decreased from the baseline ≥ 30% continuously or reached end-stage renal disease [ESRD] or died). CONCLUSION: The prognosis of those with IgAN-λ was worse than that of those with IgAN, which may be attributed to the light chain λ restriction in the mesangial deposits inducing a significant systemic inflammation manifested as severe clinical features and frequent crescent.
引用
- Zhang J, Huang Z, Lin S, et al. Clinicopathologic and Prognostic Study of Primary IgA Nephropathy With Light Chain λ Restriction in the Mesangial Deposits. Kidney Int Rep. 2022. PMID: 35497802. doi:10.1016/j.ekir.2022.01.1053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。